April 05, 2013 at 18:23 PM EDT
ResMed Still A Leader In Sleep Apnea Treatments
With about 20% of the adult population suffering from sleep-disordered breathing, ResMed (RMD) enjoys a large playing field. Moreover, the maker of devices for this ailment estimates 90% of cases are undiagnosed. ResMed is a major producer of masks and related equipment for obstructive sleep apnea, in which the airway is at least partly blocked during sleep for several seconds. "The company enjoys a competitive edge over other players in the
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here